spacer
home > pmps > winter 2020 > a rapidly changing landscape
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Rapidly Changing Landscape




In today’s dynamic and ever-changing healthcare landscape, all players must pay constant and careful attention to the challenges faced in the market and by our customers – from pharmaceutical companies and healthcare professionals to patients. Customers face increased competition for market share and faster speed-to-market, with pressure to fast track drugs and obtain earlier approvals to meet patient needs.

Contract manufacturers and drug delivery pioneers must operate on several approaches including ‘best practices’ to help drive innovation and excellence in packaging and to directly address the needs of customers and, ultimately, patients.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Tom McLean has served as Vice President, Development Engineering, R&D Innovation and Technology at West since 2016, with responsibility for the development of West delivery system products from concept through product design, verification, and validation. Tom has been working at West since the acquisition of Tech Group in 2005 and has held various senior leadership positions during this time in development engineering – leading product realisation, programme management, and sampling and business systems. Tom is a member of ISO/TC 84 (Devices for Administration of Medicinal Products and Catheters), and he holds a BS in Mechanical Engineering from Purdue University, US.
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement